Taurine promotes human mesenchymal stem cells to differentiate into osteoblast through the ERK pathway

Amino Acids

Volumn 46, Issue 7, 2014, Pages 1673-1680

  Zhou, Chenhui ^a   Zhang, Xue ^a   Xu, Liangliang ^b   Wu, Tie ^a   Cui, Liao ^a   Xu, Daohua ^a  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

ERK signaling pathway; Mesenchymal stem cell; Osteogenesis; Osteoporosis; Taurine

Indexed keywords

ALKALINE PHOSPHATASE; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; OSTEOPONTIN; OSTERIX; TAURINE; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG; 1,3 BUTADIENE DERIVATIVE; 1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ENZYME INHIBITOR; NITRILE; RUNX2 PROTEIN, HUMAN; SP7 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; MINERALIZATION; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; ANTAGONISTS AND INHIBITORS; BONE MINERALIZATION; CELL CULTURE; CELL SURVIVAL; DOSE RESPONSE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM;

ALKALINE PHOSPHATASE; BUTADIENES; CALCIFICATION, PHYSIOLOGIC; CELL DIFFERENTIATION; CELL SURVIVAL; CELLS, CULTURED; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION; HUMANS; MESENCHYMAL STROMAL CELLS; NITRILES; OSTEOBLASTS; OSTEOGENESIS; OSTEOPONTIN; SIGNAL TRANSDUCTION; TAURINE; TRANSCRIPTION FACTORS;

EID: 84903648994     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-014-1729-8     Document Type: Article

References (34)

1. Benisch P, Schilling T, Klein-Hitpass L et al (2012) The transcriptional profile of mesenchymal stem cell populations in primary osteoporosis is distinct and shows overexpression of osteogenic inhibitors. PLoS One 7(9):e45142
2. Cao L, Liu G, Gan Y et al (2012) The use of autologous enriched bone marrow MSCs to enhance osteoporotic bone defect repair in long-term estrogen deficient goats. Biomaterials 33(20):5076-5084
3. Choi MJ, Chang KJ (2013) Effect of dietary taurine and arginine supplementation on bone mineral density in growing female rats. Adv Exp Med Biol 776:335-345
4. Choi MJ, DiMarco NM (2009) The effects of dietary taurine supplementation on bone mineral density in ovariectomized rats. Adv Exp Med Biol 643:341-349
5. Dalle Carbonare L, Valenti MT, Zanatta M et al (2009) Circulating mesenchymal stem cells with abnormal osteogenic differentiation in patients with osteoporosis. Arthritis Rheum 60(11):3356-3365
6. Deal C (2009) Potential new drug targets for osteoporosis. Nat Clin Pract Rheumatol 5(1):20-27
7. Ducy P, Zhang R, Geoffroy V et al (1997) Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89(5):747-754 (Pubitemid 27516177)
8. Feng X, Li JM, Liao XB et al (2012) Taurine suppresses osteoblastic differentiation of aortic valve interstitial cells induced by beta-glycerophosphate disodium, dexamethasone and ascorbic acid via the ERK pathway. Amino Acids 43(4):1697-1704
9. Ge C, Xiao G, Jiang D et al (2007) Critical role of the extracellular signal-regulated kinase-MAPK pathway in osteoblast differentiation and skeletal development. J Cell Biol 176(5):709-718 (Pubitemid 46333984)
10. Guan M, Yao W, Liu R et al (2012) Directing mesenchymal stem cells to bone to augment bone formation and increase bone mass. Nat Med 18(3):456-462
11. Harrison G, Shapiro IM, Golub EE (1995) The phosphatidylinositol- glycolipid anchor on alkaline phosphatase facilitates mineralization initiation in vitro. J Bone Miner Res 10(4):568-573
12. 2+]i accompanied by ERK 1/2 activation in human osteoblast cells. FEBS Lett 581(30):5929-5934
13. Kanis JA, McCloskey EV, Johansson H et al (2009) Approaches to the targeting of treatment for osteoporosis. Nat Rev Rheumatol 5(8):425-431
14. Ke HZ, Richards WG, Li X et al (2012) Sclerostin and Dickkopf-1 as therapeutic targets in bone diseases. Endocr Rev 33(5):747-783
15. Lai CF, Chaudhary L, Fausto A et al (2001) Erk is essential for growth, differentiation, integrin expression, and cell function in human osteoblastic cells. J Biol Chem 276(17):14443-14450
16. Liao XB, Zhou XM, Li JM et al (2008) Taurine inhibits osteoblastic differentiation of vascular smooth muscle cells via the ERK pathway. Amino Acids 34(4):525-530
17. Nakashima K, Zhou X, Kunkel G et al (2002) The novel zinc finger-containing transcription factor Osterix is required for osteoblast differentiation and bone formation. Cell 108(1):17-29 (Pubitemid 34137009)
18. Park S, Kim H, Kim SJ (2001) Stimulation of ERK2 by taurine with enhanced alkaline phosphatase activity and collagen synthesis in osteoblast-like UMR-106 cells. Biochem Pharmacol 62(8):1107-1111 (Pubitemid 32971676)
19. Pino AM, Rosen CJ, Rodríguez JP (2012) In osteoporosis, differentiation of mesenchymal stem cells (MSCs) improves bone marrow adipogenesis. Biol Res 45(3):279-287
20. Pittenger MF, Mackay AM, Beck SC et al (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284(5411):143-147 (Pubitemid 29282067)
21. Prall WC, Haasters F, Heggebö J et al (2013) Mesenchymal stem cells from osteoporotic patients feature impaired signal transduction but sustained osteoinduction in response to BMP-2 stimulation. Biochem Biophys Res Commun 440(4):617-622
22. Rachner TD, Khosla S, Hofbauer LC (2011) Osteoporosis: now and the future. Lancet 377(9773):1276-1287
23. Rahman MM, Park HM, Kim SJ et al (2011) Taurine prevents hypertension and increases exercise capacity in rats with fructose-induced hypertension. Am J Hypertens 24(5):574-581
24. Schaffer SW, Jong CJ, Ramila KC et al (2010) Physiological roles of taurine in heart and muscle. J Biomed Sci 17(Suppl 1):S2
25. Terauchi A, Nakazaw A, Johkura K et al (1998) Immunohistochemical localization of taurine in various tissues of the mouse. Amino Acids 15(1-2):151-160 (Pubitemid 28444643)
26. Wang X, Chi D, Su G et al (2011) Determination of taurine in biological samples by high-performance liquid chromatography using 4-fluoro-7- nitrobenzofurazan as a derivatizing agent. Biomed Environ Sci 24(5):537-542
27. Wang X, Wang Y, Gou W et al (2013) Role of mesenchymal stem cells in bone regeneration and fracture repair: a review. Int Orthop 37(12):2491-2498
28. Wennberg C, Hessle L, Lundberg P et al (2000) Functional characterization of osteoblasts and osteoclasts from alkaline phosphatase knockout mice. J Bone Miner Res 15(10):1879-1888
29. Whyte MP (2010) Physiological role of alkaline phosphatase explored in hypophosphatasia. Ann N Y Acad Sci 1192:190-200
30. Yao KL, Todescan R Jr, Sodek J (1994) Temporal changes in matrix protein synthesis and mRNA expression during mineralized tissue formation by adult rat bone marrow cells in culture. J Bone Miner Res 9:231-240
31. Yao D, Xie XH, Wang XL et al (2012) Icaritin, an exogenous phytomolecule, enhances osteogenesis but not angiogenesis-an in vitro efficacy study. PLoS One 7(8):e41264
32. Yuan LQ, Xie H, Luo XH et al (2006) Taurine transporter is expressed in osteoblasts. Amino Acids 31(2):157-163 (Pubitemid 44222576)
33. Yuan LQ, Lu Y, Luo XH et al (2007) Taurine promotes connective tissue growth factor (CTGF) expression in osteoblasts through the ERK signal pathway. Amino Acids 32(3):425-430 (Pubitemid 46559573)
34. Yuan LQ, Liu W, Cui RR et al (2010) Taurine inhibits osteoclastogenesis through the taurine transporter. Amino Acids 39(1):89-99